Four research firms started covering Anthropic on its first trading day, all positive, with price targets from $125 to $155 against the $83 IPO price, according to Investing.com, TheFly and Investing.com’s ratings table.
The top target, Melius at $155, is 87% above $83. On the 13.22 billion shares the final prospectus counts, it implies about $2.05 trillion (our arithmetic).
Important: not investment advice
This article is for information and education only. It is not investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy or sell any security, ETF, option or other financial product. FourWeekMBA is not a broker-dealer or a registered investment adviser. IPO shares, leveraged and inverse ETFs, and options carry significant risk, including the loss of your entire investment; leveraged and inverse ETFs reset daily and can lose value quickly. Prices, availability, fees and eligibility change and can differ by country and broker, so check the prospectus and your broker’s terms. Figures marked “our arithmetic” are our own calculations from the cited filings and may contain errors. Do your own research and consider speaking to a licensed financial professional before making any investment decision.
Business Pill · IPO float explained
An evergreen Business Engineer explainer on IPO float. It teaches the general idea only and does not discuss these reports.
The key insight: Melius ($155), Needham ($150), Wolfe Research ($135) and Citizens ($125) opened Anthropic coverage at positive ratings on its first trading day, 51% to 87% above $83; on the 424B4’s 13,219,642,276 shares the targets imply about $1.65 trillion to $2.05 trillion (as reported; our arithmetic).
The Four Initiations
Melius analyst Ben Reitzes rated Anthropic a buy with a $155 target, Investing.com reported. The firm sees “more than $5 in long-term earnings power” with operating margins above 30%, the report said.
Needham analyst Scott Berg started at buy with a $150 target, Investing.com reported. Needham expects growth above 150% in fiscal 2027, a gross margin above 90% and operating margins above 35%.
Wolfe Research appears at $135 with a positive rating in Investing.com’s table, listed as an Outperform in a summary posted on X. We found no Wolfe note or report giving its reasons.
Citizens started at Outperform with a $125 target, TheFly reported. It called Anthropic’s approach to compute a “significant advantage”, training and serving Claude across all four major chip families as one pool.

What Was Posted on X
Unusual Whales listed four ratings and price targets after the $83 pricing: Citizens at Market Outperform ($125), Wolfe Research at Outperform ($135), Needham at Buy ($150) and Melius at Buy ($155). It adds that Needham expects revenue growth above 150% in fiscal 2027 and that Melius sees long-term earnings power above $5 a share.
What the Targets Imply
Measured against $83, the targets sit 51% (Citizens), 63% (Wolfe), 81% (Needham) and 87% (Melius) higher (our arithmetic). Their simple average, $141.25, is about 70% above the IPO price (our arithmetic).
Anthropic’s final prospectus counts 13,219,642,276 shares across all classes after the offering and placement. At $83 that is about $1.10 trillion; at the $125 to $155 targets, about $1.65 trillion to $2.05 trillion (our arithmetic).

Before trading, Bloomberg reported grey-market indications 22% to 26% above $83, as relayed on X. That is about $101 to $105 a share (our arithmetic), below all four new targets.
How Needham Gets to $150
Needham’s note, as quoted by Wall St Engine, calls Anthropic “the leading vendor in a rapidly growing AI market that could be 10% of the current $56T labor market”. Ten percent of $56 trillion is $5.6 trillion (our arithmetic).
The note says its target “equates to 18x estimated FY27 revenue or 81x free cash flow”. It puts Anthropic “in the same dominant bucket as fellow tech titans” Amazon, Alphabet and Microsoft.
Who Is Not Publishing Yet
None of the four firms, nor New Street Research, appears among the 22 banks in Anthropic’s pricing term sheet (our check). Goldman Sachs and Morgan Stanley lead that group.
FINRA Rule 2241 bars a firm that underwrote an IPO from publishing research on the issuer for “a minimum of 10 days” after the offering. So the 22 underwriting banks’ views come later.
New Street Research went first, before pricing, with a buy and a $105 target, as we reported on 17 November. That makes five positive initiations, with no neutral or negative ratings among them so far.
The Structural Read
As we read the list, the first wave of coverage comes entirely from firms outside the 22-bank underwriting group, which FINRA Rule 2241 keeps quiet for at least 10 days.
As we read Needham’s math, the $150 target rests on fiscal 2027 revenue and margin assumptions that the firm states but the prospectus does not forecast.
Needham note, as quoted by Wall St Engine, 19 Nov 2026
“our price target equates to 18x estimated FY27 revenue or 81x free cash flow”
Three Implications
FOR THE STOCK Four firms set targets of $125 to $155 against the $83 IPO price, as reported.
FOR THE UNDERWRITERS FINRA Rule 2241 bars underwriters’ research for a minimum of 10 days after an IPO.
FOR THE VALUATION The 424B4 counts 13,219,642,276 shares across all classes after the offering and placement.
What Is Not Established
We read reports of the notes, not the notes themselves, so each firm’s model and share count are as reported. Wolfe’s rating label differs between the two sources we read.
Price targets are analysts’ opinions, not forecasts of the opening trade. The debut is followed in our Anthropic IPO live blog.
The Bottom Line
Four non-underwriting firms opened coverage at $125 to $155, 51% to 87% above the $83 IPO price, while the 22 underwriting banks stay quiet for at least 10 days under FINRA Rule 2241 (our arithmetic and check).
Important: not investment advice
This article is for information and education only. It is not investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy or sell any security, ETF, option or other financial product. FourWeekMBA is not a broker-dealer or a registered investment adviser. IPO shares, leveraged and inverse ETFs, and options carry significant risk, including the loss of your entire investment; leveraged and inverse ETFs reset daily and can lose value quickly. Prices, availability, fees and eligibility change and can differ by country and broker, so check the prospectus and your broker’s terms. Figures marked “our arithmetic” are our own calculations from the cited filings and may contain errors. Do your own research and consider speaking to a licensed financial professional before making any investment decision.
97,000+ executives read Business Engineer for the AI strategy frameworks cited by ChatGPT, Claude, and Perplexity.
A note on sourcing. Ratings, targets and analyst quotes are from Investing.com, TheFly and Investing.com’s ratings table, with Needham’s wording as quoted by Wall St Engine; we did not read the research notes themselves. Wolfe Research’s target is from the Investing.com table and a summary by @DeItaone. Share count and bank list are from Anthropic’s SEC filings; the quiet period is from FINRA Rule 2241. Upsides, averages and implied values are our arithmetic. Not investment advice; for information only.
Sources: Investing.com, Needham initiates Anthropic stock coverage with buy rating, $150 target, 19 Nov 2026 · Investing.com, Melius initiates Anthropic stock with buy rating on margin outlook, 19 Nov 2026 · TheFly via TipRanks, Anthropic initiated with an Outperform at Citizens, 19 Nov 2026 · Investing.com, Anthropic stock page, analyst ratings table, read 19 Nov 2026 · Wall St Engine on X, Needham initiation quote, 19 Nov 2026 · @DeItaone on X, initiation summary, 19 Nov 2026 · Anthropic, PBC, pricing free writing prospectus, SEC EDGAR, 18 Nov 2026 · Anthropic, PBC, final prospectus (424B4), SEC EDGAR, 19 Nov 2026 · FINRA Rule 2241, Research Analysts and Research Reports









